Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
How does residual DCIS after neoadjuvant chemotherapy impact prognosis if there is a CR of the invasive disease?
Answer from: Radiation Oncologist at Community Practice
The majority of studies suggest residual DCIS has the same outcome as pCR with no invasive disease and thus is still treated as pCR in practice.
Sign in or Register to read more
17488
Related Questions
Given the final publication of NSABP B-51, for which patients meeting trial eligibility would you still recommend regional nodal irradiation?
Is stage I B/L breast, ER+ cancer a contraindication to breast radiation omission after breast conservation surgery?
How would you approach an isolated supraclavicular nodal recurrence involving the skin in a patient who has received standard chest wall and nodal radiation therapy?
How do you approach reirradiation in a patient who underwent breast-conserving surgery for recurrent breast cancer after initial lumpectomy and APBI?
What are your top takeaways in Breast Cancer from ESMO 2024?
What dose of reirradiation would you consider for locally recurrent breast cancer after mastectomy, excised with positive margins?
How are you clinically incorporating the data presented from RT Charm at ASTRO 2024?
What are your top takeaways in Medical Oncology from SABCS 2024?
How do you choose between ALND and RNI in the setting of LYMPHA or S-Lympha surgery?
How do you approach boost to the lumpectomy cavity AND 4 lymph nodes with extra-nodal extension when treating breast cancer with hypofractionation?